Scarica l'app Stockscreener
157.29
3.51%
5.34
Dopo l'orario di chiusura:
157.27
-0.02
-0.01%
Natera Inc Borsa (NTRA) Ultime notizie
Natera price target raised to $195 from $190 at BTIG - MSN
Natera raises 2025 revenue outlook to $1.94B-$2.02B with 26% growth target - MSN
Natera, Inc. (NASDAQ:NTRA) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - Yahoo Finance
UBS Raises Natera (NTRA) Price Target to $218, Maintains Buy Rat - GuruFocus
Natera First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Natera, Inc. (NASDAQ:NTRA) Q1 2025 Earnings Call Transcript - Insider Monkey
NTRA Price Target Increased as Natera Achieves Record Growth | N - GuruFocus
NTRA: Barclays Raises Price Target for Natera | NTRA Stock News - GuruFocus
Natera’s Strong Performance and Growth Potential Justifies Buy Rating - TipRanks
Natera Inc. Shines in Earnings Call with Strong Growth - TipRanks
Cathie Wood’s ARK buys Shopify, Illumina stock; sells Palantir, Natera - Investing.com
Natera Shares Dip Amid Profitability Concerns - TipRanks
RBC maintains Outperform on Natera stock, price target at $251 - Investing.com
Natera stock price target raised to $200 at TD Cowen - Investing.com
RBC maintains Outperform on Natera stock, price target at $251 By Investing.com - Investing.com India
NTRA: TD Cowen Increases Price Target on Strong Performance | NT - GuruFocus
NTRA Reports Strong Q1 Revenue Exceeding Expectations | NTRA Sto - GuruFocus
NTRA: TD Cowen Increases Price Target on Strong Performance | NTRA Stock News - GuruFocus
8 Analysts Have This To Say About Natera - Benzinga
NTRA Price Target Increased as Natera Achieves Record Growth | NTRA Stock News - GuruFocus
NTRA Stock Sees Price Target Increase by Barclays to $190 | NTRA Stock News - GuruFocus
Natera Q1 2025 slides: 37% revenue growth drives raised guidance By Investing.com - Investing.com Nigeria
Natera, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
Natera Inc (NTRA) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Raised Guidance - Yahoo Finance
Natera Inc (NTRA) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Raised Guidance By GuruFocus - Investing.com Canada
Natera Inc. Reports Strong Q1 2025 Financial Growth - TipRanks
Natera Inc earnings beat by $0.14, revenue topped estimates - Investing.com
Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Natera (NTRA) Reports Strong Q1 2025 Growth and Raises Revenue Guidance - GuruFocus
Natera Q1 2025 Earnings Call Transcript - MarketBeat
Natera (NASDAQ:NTRA) Surprises With Strong Q1, Guides for Strong Full-Year Sales - Yahoo Finance
Earnings call transcript: Natera Q1 2025 beats EPS forecast, stock rises - Investing.com UK
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Natera Inc reports results for the quarter ended March 31Earnings Summary - TradingView
NTRA Reports Strong Q1 Revenue Exceeding Expectations | NTRA Stock News - GuruFocus
Natera Q1 2025 slides: 37% revenue growth drives raised guidance - Investing.com
Natera Q1 Net Loss Narrows, Revenue Rises; Increases Full Year Revenue Outlook - marketscreener.com
Natera: Q1 Earnings Snapshot - marketscreener.com
Natera Inc (NTRA) Q1 2025 Earnings: EPS of ($0.50) Beats Estimate, Revenue Surges to $501.8 Million, Exceeding Expectations - GuruFocus
Earnings Flash (NTRA) NATERA INC. Reports Q1 Revenue $501.8M, vs. FactSet Est of $446.2M - marketscreener.com
Natera Reports First Quarter 2025 Financial Results - Yahoo Finance
Natera (NTRA) to Present Significant Breast Cancer Data at 2025 ESMO Congress | NTRA Stock News - GuruFocus
Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress | NTRA Stock News - GuruFocus
Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress - Yahoo Finance
Natera Inc (NTRA) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Cathie Wood’s ARK Makes Bold Tuesday Moves with Key Stock Swaps - Wall Street Pit
Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows - BioSpace
What To Expect From Natera’s (NTRA) Q1 Earnings - Yahoo Finance
Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas - Medical Device Network
Natera (NTRA) Highlights Promising Study Results for Sarcoma Det - GuruFocus
Natera (NTRA) Highlights Promising Study Results for Sarcoma Detection | NTRA Stock News - GuruFocus
Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera | NTRA Stock News - GuruFocus
Breakthrough: Largest-Ever Sarcoma Study Validates Natera's Cancer Detection Test with 93% Accuracy - Stock Titan
Learn to Evaluate (NTRA) using the Charts - news.stocktradersdaily.com
CLASS ACTION: Kessler Topaz Meltzer & Check, LLP Reminds Natera, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses over $250,000 to Contact the Firm - Newsfile
Notice to Shareholders of Natera, Inc. (NTRA) Regarding Dismissal of Putative Investor Class Action - TradingView
6.57%
0.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):